Comparative risk of new-onset diabetes mellitus for antihypertensive drugs: A network meta-analysis
The Journal of Clinical Hypertension | Nov 14, 2017
Li Z, et al. - In this study, researchers compared antihypertensive drugs by identifying both the advantages and disadvantages on new-onset diabetes mellitus (NOD) by focusing on their respective effect rates. Findings demonstrated that with respect to NOD, angiotensin receptor blockers had an advantage over the other treatments.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries